I have never purchased a Lexmark printer for the express reason that their profit model is based on ink and I hate to spend money on ink. I once bought my wife a new printer because it cost less than the replacement cartridges for her Lexmark printer (she bought it on her own).
That said, the stock might be ripe for a refill, an idea that I came across from an article at InvestorPlace. The idea of a merger is what got me to thinking 
Now following Forest Labs after reading several articles, including this Yahoo item.
Another lead from the Stock Gumshoe from a Motley Fool ad.
Cheap lazy tracking of a holding.
Name changed to Galena Biopharma, Inc. (GALE)
The oil crisises used to repeat every decade, yet we are winding down on the second one in the last three years. With that in mind, I have a watch for CLB to drop back to the post crisis $40 range and hopefully profit the next time I can’t afford to drive to the gas station.
I bought some at a good price awhile back and am satisfied with my current profit. The question is, should I sell and invest elsewhere or hang on expecting them to pop from some new market penetration?
Yeah, I know, I need to get around to posting the portfolio properly. Meanwhile, added on 3/10/11 @5.32
Yup, I like the funny headlines. I also like this pitch for Power One at the Fool and agree on the watch list approach. This being a common Foolish theme these days, I get the feeling the Fools see the market as over-bought at the moment.
Yeah, I should write headlines for a living. My Jr High Journalism teacher would be proud. Anyway, while it is definitely a blow to this bio tech, they have a strong pipeline, so I’m going to keep a watch on them.
I’ve been following Carl Icahn for a good stock buy in hopes of making up for the 10′s of thousands of dollars this jerk cost me from pushing the sale of my former employer. Right now, Mentor Graphics looks like a possible, if the price drops low enough before he screws their employees, too.
You are currently browsing the archives for the Trades category.